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ABSTRACT
In February 2020, a Chinese cargo ship docked at the Port of Santos with reports of crew 
members with a feverish and respiratory condition. A team was gathered to verify the existence of 
suspected cases of COVID-19 inside the vessel and define its clearance. All 25 crew members were 
interviewed, and no suspected cases were found. The vessel was then cleared for port activities. 
The investigation resulted from the implementation of the contingency plan to face a public 
health emergency of international importance and several surveillance entities cooperated.
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INTRODUCTION
On February 14, 2020, a shipping agency requested the Certificate of Free Pratique 
(operating license) to the Port of Santos, Brazil, for a cargo ship with a Hong Kong flag 
and 25 crew members on board. The expected arrival at the port was February 16, 2020. 
Among the presented documentation was the Declaration of Health and the Medical 
Logbook, in which two recent health occurrences were identified: 1) Chinese crew member 
with sore throat and cough; 2) Singaporean crew member with fever.
The ship’s last destination had been the Port of Singapore on January 21, 2020. In 
the last 30 days, the ship had also docked in the Port of Hong Kong (January 23) and 
three other Chinese ports: Yantian (January 22), Ningbo (January 19) and Shanghai 
(January 17). On January 28, 2020, China was considered an area of free transmission of the 
new coronavirus, which causes the COVID-19 disease. Anyone with respiratory symptoms 
and fever, and who had been in China in the 14 days prior to the onset of symptoms was 
considered a suspected case1,2.
COVID-19 has been considered a public health emergency of international importance by 
the World Health Organization since the end of January 20201. Given the recent passage in 
the circulation area of new coronavirus and for having symptomatic crew members, the 
national and state Emergency Operations Committees (EOC) were activated. Then a field 
team with professionals from the Brazilian Health Regulatory Agency (Anvisa), the Health 
Surveillance Center (CVE, Centro de Vigilância Epidemiológica in Portuguese) of the state 
of São Paulo, the Health Surveillance Group (GVE, Grupo de Vigilância Epidemiológica in 
Portuguese) of the region of Santos and Health Surveillance of the municipality of Santos 
was mobilized. The aim of this study was to verify the existence of cases of coronavirus 
inside the vessel and define its operating license in the port of Santos, Brazil.
METHODS
A descriptive study was conducted involving the 25 crew members of the vessel. The ship 
arrived at the Port of Santos on February 19, 2020, three days later than planned. The vessel 
was not authorized to operate, and no one was able to land. A team comprised of five 
technicians (two CVE physicians, a GVE nurse and two Anvisa ship inspection technicians) 
boarded with contact and respiratory personal protective equipment (PPE) for aerosols1,2. 
Initially, the two crew members reported as symptomatic were interviewed. Subsequently, 
the other crew members underwent the same procedure. The interview followed the 
list of crew members previously provided by the vessel’s command and was guided by 
a semi-structured questionnaire with identification variables, date and place of crew 
integration, internal function, accommodation, landing locations, previous symptoms, 
performed treatments and history of isolation. After each interview, the crew temperature 
was measured with a non-contact forehead thermometer.
While the investigation was taking place, a nurse from the health surveillance of the 
municipality of Santos waited outside the vessel equipped with PPE and material for 
collecting airway samples (swab and saline solution)1,2. Also, an ambulance was prepared 
for displacing crew members to a hospital service if necessary. 
A suspected case was defined as anyone who presented fever and at least one respiratory 
symptom (runny nose, sore throat, cough or dyspnea) from January 17, 2020 (date of passage 
by the Port of Shanghai) and up to 14 days after being in China. Given the identification of 
a crew member who fit the current definition of a suspicious case, airway samples would 
be collected from all crew members who presented feverish symptoms or any respiratory 
symptoms at the time of research. The collected samples would be sent to the Adolfo Lutz 
Institute, the public health laboratory of the state of São Paulo, for a viral panel (tests for 
3Outbreak investigation in cargo ship Fernandes EG et al.
http://doi.org/10.11606/s1518-8787.2020054002461
identification of respiratory viruses), including the reverse transcription polymerase chain 
reaction (RT-PCR) for COVID-19. The identification of a suspicious case as of January 17, 
2020 would result in the non-release of the operating license, that is, there would be no 
boarding or landing of crew or cargo.
RESULTS
The first symptomatic crew member was male, 37 years old, born in Hunan, China, and 
joined the crew at the Port of Yantian, in China on January 21, 2020. He was the vessel’s 
chief officer and usually had contact with the entire crew. His first sign of the virus 
was a sore throat on January 29, 2020, which evolved to a cough and left conjunctival 
hyperemia the next day, with no fever. He received oral amoxicillin and ciprofloxacin 
with gentamicin in eye drops. The symptoms lasted 14 days and the subject was in 
isolation during the period. He presented no complaints during the investigation, with 
a temperature of 35.5°C.
The second symptomatic crew member was a 50-year-old male from Bangkalan, Indonesia, 
and joined the crew at the Port of Singapore on January 26, 2020. He was an oiler and stayed 
in the engine room for most of his working time. He had a fever on February 10, which 
lasted three days, and denied other symptoms. He received only antipyretic medication 
(paracetamol) and progressed to cure.
The crew consisted of 23 other members, all male, aged between 24 and 54 years. Most 
were from India (8), followed by Indonesia (5), Sri Lanka (4), Myanmar (3) and Bangladesh 
(1). Besides the two symptomatic crew members, four other boarded in 2020. Three crew 
members who were already on board landed at Chinese ports and had contact with the 
local population. The others remained on the vessel. All other 23 crew members interviewed 
denied any symptoms in the last two months. The temperatures measured ranged from 
35.5 to 36.4°C. Because no crew member fit the definition of suspect case, no biological 
samples were collected.
DISCUSSION
Since January 30, 2020, the World Health Organization has declared outbreak of acute 
respiratory disease with the new coronavirus, SARS-CoV-2, as a public health emergency 
of international importance1,2. As such, all countries should be prepared to contain the 
spread of the virus by active surveillance with early detection, isolation and proper case 
management, investigation and timely notification. Therefore, the contingency plan for 
human infection with SARS-CoV-2 in the state of São Paulo stated that no vessel with any 
atypical report in its Declaration of Health or medical logbook would receive the Certificate 
of Free Pratique at the Port of Santos2. This study showed an investigation resulting from 
this awareness of surveillance in the Port of Santos.
The air and sea transport system is involved in the spread of diseases worldwide, such 
as measles, influenza and coronavirus3,4. Aircraft and vessels at maximum capacity, in 
confinement condition, facilitates the dissemination from person to person by droplets 
and aerosols, besides introducing new viruses in new areas after landing3,4. But unlike 
cruise ships4, there is no recent record of the involvement of cargo ships in the spread of 
the disease3,5.
For being a new disease, susceptibility to COVID-19 is 100%. The entry of a single case in 
the vessel would lead to transmission to the entire crew. The investigation was justified 
for the following reasons: 1) passing of the vessel by Chinese ports; 2) two recorded health 
occurrences; 3) first symptomatic case from an area of COVID-19 transmission (China); 
4) because medical assistance on a cargo ship is suboptimal5; 5) risk of introducing the 
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disease in Brazil by the Port of Santos. The investigation also validated a method of objective 
approach in respiratory isolation situation for aerosols and contact.
The two symptomatic cases did not fit the definition of suspect of COVID-19. The other crew 
members did not show any symptoms or fever at the time of the investigation. For lack of 
evidence of an outbreak of respiratory transmission disease, the ship received its Certificate 
of Free Pratique at the port of Santos. The collaboration between the various surveillance 
entities (Anvisa, CVE, GVE and the municipality of Santos) was important to enable the 
investigation of the outbreak.
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